• Bookmark and Share Email
     
  • Saturday, November 24, 2012
  • Differences in medication adherence, satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic regimens.
  • Published at: Current Drug Safety 2011 Nov 1;6(5):285-90
    1. Waleed M. Sweileh
      College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
    2. Sa\'ed H. Zyoud
      Poison Control and Drug Information Center and College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
    Abstract: 
      Sweileh WM, Ihbesheh MS, Jarar IS, Sawalha AF, Abu Taha AS, Zyoud SH, Morisky DE. Source Department of Pharmacology and Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. Abstract OBJECTIVE: To investigate differences in medication adherence, treatment satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic treatment regimens. METHODOLOGY: Medication adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8) while treatment satisfaction was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM 1.4). Psychiatric symptoms were measured using the 24-item expanded Brief Psychiatric Rating Scale (BPRS-E). Data were entered and analyzed using SPSS 16 for windows. RESULTS: A convenience sample of 131 schizophrenic patients was studied. Patients belonged to 7 groups based on their antipsychotic treatment regimens. There was no significant difference in the means of adherence (P=0.6) and BPRS domains: positive (P=0.6), negative (P=0.8), manic (P=0.2) and depression (P=0.9) scores among the studied groups. Satisfaction with side effect domain was significantly different among studied groups (P=0.006, F=3). However, no significant difference was found in other satisfaction domains: effectiveness (P=0.8), convenience (P=0.3), and global satisfaction (P=0.8). CONCLUSIONS: Medications adherence, most treatment satisfaction domains and clinical symptom scores were not significantly different among patients taking different antipsychotic regimens.
     
  • Bookmark and Share Email
     
Leave a Comment

Attachments

  • No Attachments Found for this Article

PROFILE

Sa\'ed H. A. Zyoud, PhD, Assistant Professor of Clinical Pharmacy and Toxicology
 
Show Full ProfileEnglish CV
 
 

PUBLISHED ARTICLES

GENERAL POSTS

 
Please do not email me if you do not know me
Please do not e-mail me if you do not know me